H Gisslinger, O Zagrijtschuk… - Blood, The Journal …, 2015 - ashpublications.org
In this prospective, open-label, multicenter phase 1/2 dose escalation study, we used a next-
generation, mono-pegylated interferon (IFN) α-2b isoform, ropeginterferon alfa-2b. The …